National Drugs Conference of Ireland 2011
National Drugs Conference of Ireland 2011 “Drug Interventions: What Works?
The National Drugs Conference of Ireland “Drug Interventions: What Works?” will take place in Dublin on the 3rd and 4th November 2011, in the Radisson Blu Royal Hotel Golden Lane, Dublin. This years conference will build on the success of the 2010 conference, bringing together a range of national and international speakers from across the spectrum of addiction research, service provision and policy.
Sponsorship of the conference is provided by the HSE’s National Addiction Training Programme (NATP), as part of the ongoing commitment of the HSE to work in collaboration with partners in the community, voluntary and statutory sectors addressing drug and alcohol issues.
Rory Keane, Chair of the NATP and HSE Regional Drug Co-Ordinator says, “The HSE welcomes this joint working with the Conference Steering Group, (representatives from the Irish Needle Exchange Forum, Ana Liffey Drug Project, Coolmine Therapeutic Community and the Irish Association of Alcohol and Addiction Counsellors). This is an opportunity to speak directly on the many challenges facing Irish workers in this area and for statutory and voluntary organisations to work in partnership.”
“The conference is a vital opportunity for practitioners in a range of settings to reflect not only on developments in the evidence-base for responding to addiction problems; but to also to bring this learning back to their work place and their communities.”
We shall update the list as we receive further information.
Mr João Goulao
João Goulao is the Portuguese National Drugs Coordinator and has overseen the current Portuguese Drugs policy , Chairman of the Institute on Drugs and Drug Addiction and since January 2010 Chairman of the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA). He is also Head of the national focal point in the EMCDDA’s REITOX network, member of the EMCDDA Board since 2005 and previously served on the European agency’s Scientific Committee (1997–2002). A medical doctor by profession, Dr. Goulão has over 20 years’ experience regarding drug-related issues.
Dr. Thomas McLellan
Prior to his role in federal government, Dr. McLellan was a career researcher for 35 years with the Treatment Research Institute (which he co-founded in 1992) and the University of Pennsylvania.. In his career he has published over 400 articles and chapters on addiction research. He has received several distinguished awards including Life Achievement Awards from the American, Swedish, Italian and British Societies of Addiction Medicine and most recently from the American Purblic Health Association (2010) Dr. McLellan holds a B.A. from Colgate University and his M.S. and Ph.D. from Bryn Mawr College. He received postgraduate training in psychology at Oxford University in England.
Dr Andrew Tatarsky
Dr. Andrew Tatarsky has specialized in the field of substance use treatment for over 30 years as a psychologist, supervisor, program director, lecturer and author. He is the director of the Center for Integrative Psychotherapy for Substance Misuse, a treatment and training institute, a founding board member of the Division on Addictions of New York State Psychological Association, Chairman of the Board of Moderation Management, Clinical Advisor to the New York State Office of Alcoholism and Substance Abuse Services and on the boards of several harm reduction organizations. His book, Harm Reduction Psychotherapy: A New Treatment for Drug and Alcohol Problems has been published in the United States, Chile and Poland
Dr Paolo Deluca
Dr Deluca is a Senior Research Fellow in addictive behaviour, with a background in cognitive and developmental psychology, and more than ten years experience in the addiction field. He was lead researcher and co-principal investigator on the EU funded Psychonaut 2002 and Psychonaut EWS projects on illicit drug information and availability on the Internet which have developed a web monitoring system for new recreational drugs, and an European study on drug and alcohol prevention in the workplace. Recently, he has been awarded a grant from the EU DG public health (2010-2011), which is looking at the Internet and other ICTs to deliver prevention services addressing the use of novel compounds in vulnerable individuals (ReDNet research project). Paolo Deluca has also extensive expertise on national and international clinical trial management, intervention development, delivery and evaluation with the Department of Addictions Institute of Psychiatry King’s College London London.
Greg Purvis is the Director of Addiction Services for three District Health Authorities (Colchester/East Hants, Cumberland and Pictou Counties) in Nova Scotia.
Greg has a Master’s in Clinical Psychology from Saint Mary’s University and has held various positions in the following:
- Forensic psychologist within two Federal penitentiaries
- Psychologist at a Mental Health Clinic
- Supervisor of Treatment Services for Addiction Services
Greg is one of 6 people certified internationally as a trainer in the Community Reinforcement Approach (CRA).
Greg served as a member at large for the Association of Psychologists of Nova Scotia between 2000-2002 and is a registered clinical psychologist with the Nova Scotia Board of Examiners in Psychology. He is currently chair of the Atlantic Canadian Counsel on Addictions.
Martin Woods has worked in the anti-money laundering space ever since 1984 when the first drug trafficking act offences became law in the UK . He has been investigating money laundering and money launderers for in excess of 25 years, initially as a police officer, then as a money laundering reporting He has a wealth of experience as an investigator He was a member of the National Crime His experience enables him to deliver real life case studies which draw upon a deep reservoir of anecdotal money laundering cases.
Brian has worked in health and social care for 13 years managing services across a variety of treatment sectors. He has managed generic treatment services across London and developedstimulant and crack cocaine provision in Wandsworth and Greenwich. He was a member of the National Treatment Agency working party that evaluated and modified ITEP materials at The Institute of Behavioural Research in Texas and has lead the implementation of ITEP across Blenheim CDP and as a training package for the sector. He has an MA in Health and Social Care Management and is presently a post graduate student in Organisational Consultation at the Tavistock Institute . Brian is currently Director of Client services at Blenheim CDP.
Martin has worked in drug and alcohol treatment within London for over twenty-five years He has developed and led a wide range of treatment services across London and (with enthusiasm!) contributed to many of the developments in the UK drug treatment field including QuADS, ITEP, and stimulant specific treatment services. Martin is a qualified Practice Teacher and possesses a Post Graduate Diploma in Substance Misuse. He has also just completed an MA Leadership and Strategic Management at the Tavistock Institute and currently works as a Director of Client Services at Blenheim CDP.
Pavee Point Travellers Centre Research Launch
Meeting the needs of Travellers - Good practice guidelines for drug & alcohol services.
Drug Conference Promotional video
In this video, Tim Bingham, a member of the Conference Steering Group, provides additional information relating to this years conference.